Featured Articles
-
PAT Implementation For ADC And Bioconjugation Processes
3/1/2024
Explore expert insights into the implementation of Process Analytical Technology (PAT) for ADC and bioconjugation processes and the pros and cons of in(on)line testing for the conjugation process.
-
Advancements In Process And Payload Development
2/29/2024
Continuous advancements in the process and payload development of ADCs and next-generation bioconjugates have the potential to progress targeted therapeutics and improve patient treatment options.
-
Characterization Of Host Cell Proteins By Liquid Chromatography - Mass Spectrometry
2/26/2024
Explore an established liquid chromatography – tandem mass spectrometry (LC-MS/MS) method for characterization of residual HCPs in monoclonal antibody (mAb) products.
-
Scalability And Performance Of Mobius® iFlex Bioreactors
1/19/2024
Utilizing single-use bioreactors in intensified fed-batch and perfusion processes can help manufacturers produce a high-quality drug supply while reducing facility footprint and production costs.
-
Streamlining And Enhancing Gene Therapy Production With Automation
1/9/2024
When it comes to determining the appropriate analytics to inform early development, there are a number of variables to consider surrounding cost, operator expertise, and throughput.
-
What To Consider For A Modular Facility With Closed Processing
1/2/2024
The emerging trends in the biopharmaceutical industry are driving an even greater need for modular facilities and closed processing. Learn about the progression toward closed processing and more.
-
The Post-Pandemic Supply Chain: Improving Resilience Via Value Chains
11/14/2023
The COVID-19 pandemic underscored the vulnerability of global supply chains. Explore lessons learned from the pandemic, the concept of supply chain resilience, what to look for in a supplier, and more.
-
Optimizing And Scaling Lentiviral Vector Production
10/23/2023
Here, we outline how the upstream and downstream workflows of the VirusExpress® platform for lentiviral vectors were optimized through the use of design of experiments and supplementary studies.
-
Accelerate Development And De-Risk Gene Therapy Manufacturing
10/20/2023
Join viral vector process and analytical development experts as they showcase strategies for developing robust processes and analytics for efficient and de-risked manufacturing.
-
Reducing The Level Of Host Cell Proteins In The Bioreactor Harvest
10/20/2023
Learn how MilliporeSigma helped a customer drastically reduce the level of HCPs in the bioreactor harvest prior to a production run to supply drug substance for a scheduled Phase 1 clinical trial.